Development and Validation of a Rapid and Simple LC‐MS/MS Method for Quantification of the Anti‐Microtubule, Anti‐Cancer Agent ABT‐751 in Human and Mouse Plasma and Mouse Tissues
Aristeidis Lentzas(The Netherlands Cancer Institute), Olaf van Tellingen(The Netherlands Cancer Institute), Mark C. de Gooijer(Manchester Academic Health Science Centre), Anna Their(Dutch Cancer Society), Jos H. Beijnen(Utrecht University)
Cited by 0
Related Papers
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
ABCB1, ABCG2, and PTEN Determine the Response of Glioblastoma to Temozolomide and ABT-888 Therapy
|Clinical Cancer Research|2014|147
Improved Brain Penetration and Antitumor Efficacy of Temozolomide by Inhibition of ABCB1 and ABCG2
|Neoplasia|2018|137
An Experimenter’s Guide to Glioblastoma Invasion Pathways
|Trends in Molecular Medicine|2018|125